 |
 |
|
|
|
|
|
|
 | | Developing minimally-invasive drug-device convergence products for localized drug delivery
| | Private
| | 2009
|
 |
 | | Developing incision-less vision correction procedures
| | Private
| | 2009
|
|
 | | Developing on-body health awareness products
| | Private
| | 2007
|
|
 | | Developing sensitive, precise and robust platform for single molecule analysis
| | Private
| | 2007
|
|
 | | Developing transformative in vitro and in vivo diagnostic products
| | Private
| | 2006
|
|
 | | Develops real-time tools to monitor thermal ablation of tumors
| | Private
| | 2005
|
|
 | | Developing in vivo molecular imaging systems to detect and treat disease
| | Private
| | 2005
|
|
 | | Developing platform to synthesize compounds for drug discovery and biodetection
| | Private
| | 2004
|
|
 | | Developing cell-based therapies that induce repair and regeneration in a wide array of tissues
| | Private
| | 2003
|
|
 | | Developing high throughput, single-molecule DNA sequencing platform
| | Public (Nasdaq: HLCS)
| | 2003
|
|
 | | Developing systems to prolong the health of transplantation organs
| | Private
| | 2003
|
|
 | | Developing tools and technologies applying systems biology to drug discovery and development
| | Private
| | 2000
|
|
